Gen Z and Millennials are adopting the No Buy 2025 spending challenge to combat inflation and boost personal savings through minimalist consumption.
While 2025 optimism remains high, emerging risks from inflation and trade policy are forcing investors to reconsider their positions.
Big banks report stellar Q4 profits, fueling optimism for 2025 as the financial sector rallies on strong investment banking and trading performance.
Production delays at Boeing and Airbus are fueling an aircraft shortage, forcing airlines to rely on lessors and driving up industry lease rates.
Johnson & Johnson is acquiring Intra-Cellular Therapies for $14.6 billion, signaling a strategic focus on neuroscience as existing drug patents near expiration.